Polymeric Modification Agent for Break-Free Genetic Editing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current gene editing and genome engineering methods face limitations in versatility and precision, often requiring DNA breaks that can lead to off-target effects and chromosomal rearrangements, and are not effective for multi-nucleotide changes or deletions.

Innovation Solution

The use of a polymeric modification agent, such as a DLR molecule, that binds to DNA without causing breaks, combined with a sequence modification polynucleotide, to achieve genetic modifications by temporarily stalling replication and utilizing mismatch repair and replication fork restart mechanisms for targeted nucleotide changes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If DNA breaks are introduced for gene editing, then genetic modification can be achieved, but off-target effects and chromosomal rearrangements occur

Engineering Contradiction:
Improvegenetic modification precisionVSAvoidoff-target effects and chromosomal rearrangements
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the harmful DNA breakage step from the gene editing process. The system achieves genetic modification through template-directed repair of stalled replication forks without requiring double-strand breaks, thereby eliminating off-target effects and chromosomal rearrangements while maintaining precise genetic modification capability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces an intermediary mechanism (stalled replication fork with template DNA) to mediate genetic modification. Instead of directly breaking DNA, the system uses a stalled replication fork as an intermediary structure that allows template-directed repair, achieving precise genetic modification without the harmful effects of direct DNA breakage

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If conventional gene editing methods are used, then some genetic modifications can be achieved, but versatility for multi-nucleotide changes and deletions is limited

Engineering Contradiction:
Improveversatility for multi-nucleotide changes and deletionsVSAvoidediting accuracy
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The invention creates a universal gene editing system that can perform multiple functions including multi-nucleotide changes, deletions, and insertions. The stalled replication fork mechanism serves as a universal platform that accommodates various types of genetic modifications through template-directed repair, greatly enhancing versatility while maintaining precision

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables precise and efficient genetic modifications with minimal off-target effects, allowing for versatile gene editing and engineering without introducing DNA breaks, thereby enhancing the safety and efficacy of gene therapy applications.

Implementation Method 1

a polymeric modification agent, such as a DLR molecule, that binds to DNA without causing breaks

Methodology Applied
Scientific EffectDNA binding:

Implementation Method 2

achieve genetic modifications by temporarily stalling replication and utilizing mismatch repair and replication fork restart mechanisms

Methodology Applied
Scientific EffectReplication fork stalling:

Implementation Method 3

utilizing mismatch repair and replication fork restart mechanisms for targeted nucleotide changes

Methodology Applied
Scientific EffectMismatch repair:

Data Source

PatentUS20240287547A1Genetic modification
Publication Date: 2024.08.29 PETER BIOTHERAPEUTICS INC
  • US20240287547A1 patent drawing
  • US20240287547A1 patent drawing
  • US20240287547A1 patent drawing

AI summary

The present disclosure provides technologies for genetic modification without a need for introduction of one or more breaks into any genetic material being modified.